JPRN-UMIN000004813已完成2 期
Risk and safety to stop antiplatelet (aspirin)to perform an initial diagnostic endoscopy - Risk and safety to stop aspirin to perform an endoscopy
Graduate School of Medical Sciences, Kumamoto University0 个研究点目标入组 50 人开始时间: 2011年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Malignancy, Zollinger-Ellison syndrome, pregnancy, a history of esophago-gastric surgery, continue bleeding from the GI tract, can not use the cilostazol, and can not take informed consent.
研究者
相似试验
已完成
不适用
Discontinuation of aspirin as primary prevention and cardiovascular events in diabetesDiabetic patient at risk of atherosclerotic cardiovascular diseaseAspirin discontinuationprimary preventionDiabetes mellitusTCTR20220114002/A298
招募中
1 期
Aspirin to prevent cardiovascular events in patients with pneumoniaPneumonia, Myocardial infarctionCTIS2023-504553-12-01Amsterdam UMC760
进行中（未招募）
不适用
To compare the effects of different aspirin regimens ( 100mg/d, 200mg/d, 100+100 mg b.i.d.) to patients undergoing coronary artery bypass grafting and/or aortic valve replacement with bioprosthesisEUCTR2011-001488-40-ITFONDAZIONE MONZINO CENTRO CARDIOLOGICO
招募中
4 期
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome PatientsNon ST Segment Elevation Acute Coronary SyndromeNCT05125276Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3,090
尚未招募
不适用
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular DiseaseHealthy Participants With Moderate and High Cardiovascular RiskNCT03757156Yonsei University4,118